MARKSANS PHARMA
Back to Cashflow Statement
|
MARKSANS PHARMA Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹-141 Cr | ₹-259 Cr | ₹-84 Cr | ₹-45 Cr | ₹-60 Cr |
What is the latest Cash Flow from Investing Activities ratio of MARKSANS PHARMA ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2024 | ₹-141 Cr |
Mar2023 | ₹-259 Cr |
Mar2022 | ₹-84 Cr |
Mar2021 | ₹-45 Cr |
Mar2020 | ₹-60 Cr |
How is Cash Flow from Investing Activities of MARKSANS PHARMA Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-141 Cr | Negative | |
Mar2023 | ₹-259 Cr | Negative | |
Mar2022 | ₹-84 Cr | Negative | |
Mar2021 | ₹-45 Cr | Negative | |
Mar2020 | ₹-60 Cr | - |
Compare Cash Flow from Investing Activities of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹13,446.4 Cr | -2.1% | -14.4% | 85% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹452,155.0 Cr | 3.7% | 8.5% | 49.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,929.0 Cr | 3.6% | 1.8% | 52.1% | Stock Analytics | |
CIPLA | ₹123,525.0 Cr | 3% | 1.9% | 20.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹115,839.0 Cr | 2.7% | 15.5% | 23.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,750.6 Cr | -1.6% | 1% | 43.9% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | -2.1% |
-14.4% |
85% |
SENSEX | -0.5% |
-1.1% |
9.5% |
You may also like the below Video Courses